ACLX
ArcellxยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ACLX Profile
Arcellx, Inc.
A company that develops innovative immunotherapies for cancer
800 Bridge Parkway, Redwood City, CA 94065
--
Arcellx, Inc., was incorporated in Delaware in December 2014. They are a clinical-stage biotechnology company reimagining cell therapy by developing innovative immunotherapies for patients with cancer and other incurable diseases. Their new synthetic binding scaffold D-Domain aims to overcome the limitations of traditional chimeric antigen receptor T cells.
